China-based OUR United Corporation, a leading provider of radiosurgical solutions, has filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. Specific details regarding the unit price and other key aspects of the IPO have not been disclosed at this stage.
Company Overview and Core Products
OUR United has established a comprehensive treatment matrix that includes multiple approved and investigational solutions since its inception in 2011. The company’s core product, CybeRay, is the world’s first real-time image-guided gamma ray surgery system. It has received regulatory approval in the United States in March 2021 and in China in July 2022. Another flagship product, TaiChiRT Pro, is the world’s first X/gamma ray integrated radiation therapy system to receive FDA Breakthrough Device designation.-Fineline Info & Tech
